Journal of Biopharmaceutical Statistics

Scope & Guideline

Bridging biostatistics and pharmacology for impactful research.

Introduction

Explore the comprehensive scope of Journal of Biopharmaceutical Statistics through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Journal of Biopharmaceutical Statistics in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1054-3406
PublisherTAYLOR & FRANCIS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1991 to 2024
AbbreviationJ BIOPHARM STAT / J. Biopharm. Stat.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The Journal of Biopharmaceutical Statistics focuses on the application of statistical methodologies in the biopharmaceutical field, particularly in clinical trial design and analysis. It aims to advance the understanding and implementation of statistical techniques that enhance the quality and effectiveness of drug development processes.
  1. Clinical Trial Design and Analysis:
    The journal emphasizes innovative statistical methodologies for designing and analyzing clinical trials, including adaptive designs, Bayesian approaches, and multi-arm trial strategies.
  2. Pharmacokinetics and Pharmacometrics:
    Research often involves the integration of pharmacokinetic (PK) and pharmacodynamic (PD) modeling to optimize drug dosing and assess treatment efficacy in various populations.
  3. Real-World Evidence and Data Integration:
    A significant focus is placed on leveraging real-world data (RWD) and external controls to inform clinical trials and enhance regulatory submissions.
  4. Machine Learning and Statistical Learning:
    The journal explores the application of machine learning techniques in biostatistics, particularly for predicting treatment outcomes and analyzing complex datasets.
  5. Biomarker Development and Validation:
    Research includes the statistical evaluation of biomarkers in clinical trials, particularly for personalized medicine and targeted therapies.
  6. Statistical Methods for Safety Monitoring:
    The journal addresses methodologies for robust safety monitoring and signal detection in clinical trials, ensuring patient safety and regulatory compliance.
The Journal of Biopharmaceutical Statistics has identified several trending and emerging themes that reflect the evolving landscape of biostatistics in the context of drug development and clinical trials.
  1. Adaptive and Seamless Trial Designs:
    A growing trend is the emphasis on adaptive trial designs that allow for modifications based on interim results, enhancing flexibility and efficiency in clinical development.
  2. Integration of Machine Learning with Traditional Methods:
    There is an increasing scholarly interest in combining machine learning techniques with traditional statistical methods to improve predictions and analyses in clinical trials.
  3. Focus on Patient-Centric Outcomes:
    Research is increasingly oriented towards patient-reported outcomes (PROs) and meaningful clinical endpoints, reflecting a shift towards more patient-centered drug development.
  4. Utilization of Real-World Data (RWD):
    The integration of RWD into clinical trial methodology is gaining momentum, as researchers seek to enhance the generalizability of trial results and support regulatory submissions.
  5. Bayesian Hierarchical Models:
    The application of Bayesian hierarchical models for complex data structures and multi-level trials is becoming more prevalent, providing robust frameworks for analysis.
  6. Methodological Advances in Biomarker-Driven Trials:
    There is a surge in research focused on biomarker-driven trial designs, which combine statistical expertise with biological insights to optimize treatment strategies.

Declining or Waning

While the journal continues to thrive in various research areas, some themes have seen a decline in focus over recent years. This may be attributed to evolving methodologies or shifting priorities in biopharmaceutical statistics.
  1. Traditional Frequentist Approaches:
    There has been a noticeable decrease in the publication of studies solely relying on traditional frequentist statistical methods, as the field increasingly favors Bayesian methodologies and adaptive designs.
  2. Basic Statistical Theory:
    Research focused on fundamental statistical theories, without direct application to biopharmaceutical contexts, has waned as the journal prioritizes practical applications and innovative designs.
  3. Generalized Linear Models (GLMs):
    While GLMs remain important, the specific focus on these models has diminished, with more complex and flexible modeling approaches gaining traction.
  4. Cohort Studies without Advanced Analysis Techniques:
    There is a decline in the publication of cohort study analyses that do not employ advanced statistical techniques, reflecting a shift towards more sophisticated methodologies in trial designs.

Similar Journals

Chilean Journal of Statistics

Bridging theory and application in the world of statistics.
Publisher: SOC CHILENA ESTADISTICA-SOCHEISSN: 0718-7912Frequency: 2 issues/year

The Chilean Journal of Statistics is a vital resource for researchers, professionals, and students dedicated to the field of statistics and probability. Published by SOC CHILENA ESTADISTICA-SOCHE, this journal serves as a platform for the dissemination of innovative research and advancements in statistical methodologies, data analysis, and applications. With an ISSN of 0718-7912 and E-ISSN 0718-7920, the journal features contributions from the statistical community in Chile and beyond, reflecting its growing influence as evidenced by its classification in the Q3 quartile for 2023. Operating out of Chile, specifically from Santiago, the journal aims to converge its scope from 2019 to 2024 on providing high-quality, peer-reviewed articles that can inform and inspire academic and professional practices. While it is not an open-access journal, it remains a crucial outlet for impactful statistical research, fostering a deeper understanding of statistical concepts and their real-world applications.

Journal of Official Statistics

Connecting Researchers with Cutting-Edge Statistical Insights
Publisher: SAGE PUBLICATIONS INCISSN: 0282-423XFrequency: 4 issues/year

The Journal of Official Statistics, published by SAGE Publications Inc, is a premier open-access journal that has been fostering advancements in the field of statistics since its inception. With its focus on disseminating high-quality research from 1986 to present, this journal provides a vital platform for statistical practices, innovations, and methodologies applicable to various domains, including governmental and organizational data analysis. Recognized as a Q2 journal in the Statistics and Probability category with a Scopus ranking of #143 out of 278, the Journal of Official Statistics boasts a significant impact in informing statisticians and practitioners alike. Located in Sweden, this journal has embraced open access since 2013, ensuring that its comprehensive and research-driven content is accessible to a global audience. Whether you are a researcher, professional, or student, this journal serves as an essential resource for staying informed about the latest trends and discussions in the official statistical community.

Japanese Journal of Statistics and Data Science

Cultivating Knowledge at the Intersection of Data and Theory
Publisher: SPRINGERNATUREISSN: 2520-8756Frequency: 2 issues/year

Japanese Journal of Statistics and Data Science, published by SPRINGERNATURE, is a leading academic journal dedicated to the advancement of statistical methodologies and data science applications, with a focus on fostering innovative research and discourse within the field. Since its inception in 2018, the journal has sought to bridge theory and practice, embracing emerging trends and interdisciplinary approaches that contribute to the ever-evolving landscape of statistics, probability, and computational theory. Hailing from Germany, the journal holds an impressive Q3 ranking in both Computational Theory and Mathematics and Statistics and Probability, reflecting its commitment to high-quality, impactful research. With an accessible ISSN of 2520-8756 and E-ISSN 2520-8764, the journal invites a global audience of researchers, professionals, and students to explore its rich array of articles and findings, all aimed at furthering knowledge and application in the realm of data science.

PHARMACEUTICAL STATISTICS

Unlocking the Potential of Pharmaceuticals with Robust Statistics
Publisher: WILEYISSN: 1539-1604Frequency: 6 issues/year

PHARMACEUTICAL STATISTICS is a premier academic journal published by Wiley, focusing on the intersection of pharmacology and statistics. With the ISSN 1539-1604 and E-ISSN 1539-1612, this journal has established itself as a leading resource in the field since its inception in 2004, with a targeted convergence year extending to 2024. Notably, it ranks in the Q1 category for both pharmacology and statistics, reflecting its high impact and significance within these disciplines. The journal embraces a wide scope, encompassing statistical methodology and its application in pharmaceuticals, thus serving as an essential platform for researchers, professionals, and students committed to advancing their knowledge and practice. Its notable placement in Scopus rankings further reinforces its academic credibility, making it a valuable reference point for high-quality research. Although this journal does not currently offer open access options, it remains a vital source of insights and research advancements in the pharmaceutical sciences.

Statistics in Biopharmaceutical Research

Elevating drug development through innovative statistical solutions.
Publisher: TAYLOR & FRANCIS INCISSN: 1946-6315Frequency: 4 issues/year

Statistics in Biopharmaceutical Research, published by Taylor & Francis Inc, is a premier journal that occupies a crucial space in the realms of Pharmaceutical Science and Statistics and Probability. With a robust impact factor affirmed by its Q1 rankings in both categories, the journal stands as a beacon for innovative statistical methodologies and their applications in biopharmaceutical research. Researchers and professionals will find a rich repository of high-quality articles that address contemporary challenges in drug development, clinical trials, and regulatory frameworks. Since its inception in 2011, the journal has continued to foster interdisciplinary collaboration, making significant strides towards enhancing statistical practice in biomedicine. With a commitment to academic rigor and practical relevance, Statistics in Biopharmaceutical Research is an essential resource for anyone looking to advance their understanding and application of statistical techniques in the pharmaceutical industry.

INTERNATIONAL STATISTICAL REVIEW

Elevating Insights in Statistics and Probability
Publisher: WILEYISSN: 0306-7734Frequency: 3 issues/year

INTERNATIONAL STATISTICAL REVIEW is a prestigious journal published by Wiley, recognized for its significant contributions to the field of statistics and probability. With an impact factor reflecting its high citation rate and ranking in the top quartile (Q1) of relevant categories, this journal is a vital resource for researchers, professionals, and students alike. Covering a broad range of topics within statistical theory and application, it aims to disseminate innovative research findings and methodological advancements that shape the discipline. The journal's extensive history, converging years from 1982 to 2024, establishes its longstanding commitment to fostering scholarly communication in statistics. While it operates under a subscription model, its rigorous peer-review process ensures that published articles are of the highest quality, providing readers with insightful, reliable, and impactful content. For those looking to stay at the forefront of statistical research, the INTERNATIONAL STATISTICAL REVIEW is an indispensable addition to their academic resources.

BIOMETRICS

Connecting Disciplines Through Exceptional Research
Publisher: WILEYISSN: 0006-341XFrequency: 4 issues/year

BIOMETRICS, published by WILEY, stands as a prestigious journal that has made substantial contributions across diverse fields, including Agricultural and Biological Sciences, Applied Mathematics, and Biochemistry. With an impressive track record from its inception in 1946 and continuing through to 2024, this journal is recognized for its rigorous peer-reviewed research and high-impact findings, evidenced by its Q1 ranking in various categories such as Medicine and Statistics. Researchers and professionals alike will find a wealth of knowledge within its pages, making it an essential resource for anyone involved in these dynamic and evolving disciplines. While BIOMETRICS does not offer open access, its reputation for delivering high-quality research ensures its continued importance in advancing the scientific ecosystem. For those seeking to stay ahead in their fields, engaging with the latest studies published in this journal is indispensable.

Austrian Journal of Statistics

Your Gateway to Cutting-Edge Statistical Discoveries
Publisher: AUSTRIAN STATISTICAL SOCISSN: 1026-597XFrequency: 2 issues/year

Austrian Journal of Statistics, published by the AUSTRIAN STATISTICAL SOC, serves as a prominent platform for disseminating innovative research in the fields of statistics and applied mathematics. Established as an open-access journal in 1996, it aims to promote the exchange of knowledge and advancements among researchers, academics, and practitioners, particularly in Austria and beyond. With an ISSN of 1026-597X, this journal has gained recognition despite its current standing in the lower quartiles in various Scopus rankings. It covers a wide breadth of topics including statistics, probability, and uncertainty, appealing to a diverse audience of researchers aiming to enhance their understanding of these critical disciplines. By offering unrestricted access to its content, the Austrian Journal of Statistics provides invaluable resources for both emerging and established voices in the field, making it a vital source for academics and professionals alike. Research published here contributes to the ongoing dialogue surrounding statistical methodologies and applications, making it indispensable for anyone engaged in data analysis and interpretation.

Clinical Pharmacology in Drug Development

Empowering professionals with cutting-edge pharmacological insights.
Publisher: WILEYISSN: 2160-7648Frequency: 6 issues/year

Clinical Pharmacology in Drug Development, published by WILEY, is a distinguished journal dedicated to advancing the field of pharmaceutical science and drug development. With a strong commitment to disseminating cutting-edge research, this journal serves as a crucial platform for professionals, researchers, and students aiming to enhance their understanding of pharmacological principles and innovations in medical therapeutics. Since its inception in 2012, the journal has consistently maintained a noteworthy presence in the academic community, currently achieving a Q2 ranking in both Pharmaceutical Science and Medical Pharmacology categories as of 2023. Although the journal operates under a subscription model, it is highly regarded for its rigorous peer-reviewed publications, offering insights into drug efficacy, safety, and regulatory challenges. Positioned at the intersection of clinical practices and pharmaceutical advancements, Clinical Pharmacology in Drug Development plays an essential role in bridging the gap between scientific research and real-world application, ensuring that the latest therapeutic strategies are optimized for patient care.

BIOSTATISTICS

Championing excellence in biostatistical research and application.
Publisher: OXFORD UNIV PRESSISSN: 1465-4644Frequency: 4 issues/year

BIOSTATISTICS is a premier academic journal dedicated to the intersection of statistical methodologies and their applications in the field of biomedicine, published by Oxford University Press. With its ISSN 1465-4644 and E-ISSN 1468-4357, the journal has established itself as a crucial resource for researchers and professionals in the broad disciplines of statistics and probability, particularly within medical contexts. The journal proudly holds a Q1 ranking in multiple categories as of 2023, including Medicine (miscellaneous), Statistics and Probability, as well as Statistics, Probability, and Uncertainty, placing it at the forefront of statistical research. It has also achieved notable Scopus rankings, underscoring its influence and reach—ranking 27th in Mathematics (Statistics and Probability) and 94th in Medicine (General Medicine). Although it does not currently offer open access options, BIOSTATISTICS remains committed to advancing scholarly conversation and innovation in statistical science, making it an essential outlet for both established and emerging researchers. With contributions spanning from 2003 to 2024, this journal is actively seeking to foster an understanding of complex statistical approaches in biomedicine, enabling professionals in the field to apply robust statistical techniques to real-world problems.